US Bancorp’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-465
| Closed | -$15K | – | 4326 |
|
|
2022
Q2 | $15K | Sell |
465
-5,721
| -92% | -$181K | ﹤0.01% | 3227 |
|
|
2022
Q1 | $163K | Buy |
6,186
+1,223
| +25% | +$29.9K | ﹤0.01% | 2048 |
|
|
2021
Q4 | $117K | Buy |
4,963
+1,301
| +36% | +$32.1K | ﹤0.01% | 2225 |
|
|
2021
Q3 | $93K | Buy |
3,662
+551
| +18% | +$14K | ﹤0.01% | 2342 |
|
|
2021
Q2 | $80K | Buy |
+3,111
| New | +$84.6K | ﹤0.01% | 2433 |
|
|
2021
Q1 | – | Sell |
-16
| Closed | – | – | 4009 |
|
|
2020
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 3934 |
|
|
2020
Q3 | $0 | Sell |
16
-4,254
| -100% | -$80.4K | ﹤0.01% | 3918 |
|
|
2020
Q2 | $93K | Sell |
4,270
-805
| -16% | -$18.4K | ﹤0.01% | 2148 |
|
|
2020
Q1 | $117K | Sell |
5,075
-863
| -15% | -$25.1K | ﹤0.01% | 1947 |
|
|
2019
Q4 | $196K | Buy |
5,938
+3,031
| +104% | +$97.1K | ﹤0.01% | 1841 |
|
|
2019
Q3 | $93K | Sell |
2,907
-1,380
| -32% | -$40.2K | ﹤0.01% | 2190 |
|
|
2019
Q2 | $110K | Buy |
4,287
+1,791
| +72% | +$45.6K | ﹤0.01% | 2163 |
|
|
2019
Q1 | $63K | Sell |
2,496
-1,717
| -41% | -$51.2K | ﹤0.01% | 2391 |
|
|
2018
Q4 | $143K | Sell |
4,213
-745
| -15% | -$24.2K | ﹤0.01% | 1933 |
|
|
2018
Q3 | $177K | Sell |
4,958
-415
| -8% | -$14.7K | ﹤0.01% | 1933 |
|
|
2018
Q2 | $185K | Buy |
5,373
+631
| +13% | +$22.1K | ﹤0.01% | 1903 |
|
|
2018
Q1 | $159K | Buy |
4,742
+2,125
| +81% | +$67.3K | ﹤0.01% | 2013 |
|
|
2017
Q4 | $100K | Sell |
2,617
-36
| -1% | -$1.44K | ﹤0.01% | 2260 |
|
|
2017
Q3 | $100K | Buy |
2,653
+878
| +49% | +$31K | ﹤0.01% | 2238 |
|
|
2017
Q2 | $66K | Buy |
1,775
+90
| +5% | +$3.25K | ﹤0.01% | 2406 |
|
|
2017
Q1 | $66K | Buy |
1,685
+532
| +46% | +$20K | ﹤0.01% | 2348 |
|
|
2016
Q4 | $40K | Sell |
1,153
-544
| -32% | -$21.4K | ﹤0.01% | 2565 |
|
|
2016
Q3 | $67K | Sell |
1,697
-305
| -15% | -$12.2K | ﹤0.01% | 2292 |
|
|
2016
Q2 | $76K | Sell |
2,002
-1,390
| -41% | -$46.6K | ﹤0.01% | 2209 |
|
|
2016
Q1 | $130K | Buy |
3,392
+535
| +19% | +$19.9K | ﹤0.01% | 1883 |
|
|
2015
Q4 | $137K | Buy |
2,857
+1,726
| +153% | +$79.9K | ﹤0.01% | 1886 |
|
|
2015
Q3 | $45K | Sell |
1,131
-2,280
| -67% | -$96.9K | ﹤0.01% | 2514 |
|
|
2015
Q2 | $145K | Sell |
3,411
-302
| -8% | -$12K | ﹤0.01% | 1924 |
|
|
2015
Q1 | $147K | Sell |
3,713
-2,672
| -42% | -$98.5K | ﹤0.01% | 1926 |
|
|
2014
Q4 | $230K | Buy |
6,385
+4,602
| +258% | +$155K | ﹤0.01% | 1710 |
|
|
2014
Q3 | $53K | Buy |
1,783
+170
| +11% | +$4.69K | ﹤0.01% | 2465 |
|
|
2014
Q2 | $41K | Sell |
1,613
-3,576
| -69% | -$88.4K | ﹤0.01% | 2581 |
|
|
2014
Q1 | $134K | Buy |
+5,189
| New | +$131K | ﹤0.01% | 1966 |
|
Other funds holding NTUS
US Bancorp's NTUS Position: Q3 2022 in Review
US Bancorp sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 465 shares — an estimated $15K sold.
US Bancorp first reported a position in NTUS in Q1 2014 and held it in 33 quarters. The position peaked at $230K in Q4 2014. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- US Bancorp reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- US Bancorp sold 465 Natus Medical Inc shares in Q3 2022, an estimated $15K.
- US Bancorp first reported a position in Natus Medical Inc in Q1 2014 and held it in 33 quarters.
- US Bancorp's Natus Medical Inc position peaked at $230K in Q4 2014.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on US Bancorp's 13F filing for Q3 2022, filed 27 Oct 2022.